Ethics versus evidence in influenza vaccination

Lancet

Volumn 364, Issue 9452, 2004, Pages 2161-2163

  Zambon, Maria C ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGE DISTRIBUTION; COMORBIDITY; DISEASE DURATION; EPIDEMIC; HEALTH PROGRAM; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; NOTE; PREDICTION; PRIORITY JOURNAL;

EID: 10944252009     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17608-3     Document Type: Note

References (20)

1. Gibbens A, Reith lecture no.2: risk. Runaway World ISBN 0 415 92719 6, Routledge, 1999.
2. Medicines and Healthcare products Regulatory Agency. Oct 6, 2004: http://www.mhra.gov.uk/news/2004/chironfluvaccine.htm (accessed Dec 13, 2004).
3. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 292:2004;1333-1340
4. van Essen GA, Palache AM, Farleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine. 21:2003;1780-1785
5. Harper SA, Fukuda K, Uyeki TM, and the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the advisory committee on immunisation practices (ACIP). MMWR Morbid Mortal Wkly Rep 2004; 53: 1-40.
6. Mitka M. Health officials brace for flu season. JAMA. 292:2004;1670-1671
7. Wilson LE, Zambon MC, McMenamin J. Influenza associated deaths in children from England and Scotland over the winter 2003/2004. European Virology Conference, Madrid, September, 2004: poster.
8. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine Nov 2, 2004 [epub ahead of print).
9. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 344:2001;889-896
10. Irish C, Alli M, Gilham C, Jospeh CA, Watson JM. Influenza vaccine uptake and distribution in England and Wales July 1989-June 1997 Health Trends. 30:1998;51-55
11. Donaldson L, Mullally S, Smith J. Update on the influenza and pneumococcal immunisation programmes. London: Department of Health, Aug 9, 2004: http://www.dh.gov.uk/assetRoot/04/08/73/40/04087340.pdf (accessed Dec 10, 2004).
12. Treanor J. Weathering the influenza vaccine crisis (2004). N Engl J Med. 351:2004;2037-2040
13. J Sainsbury plc archives. Fare shares. 2001: http://www.j-sainsbury.co. uk/museum/ration.htm (accessed Dec 10, 2004).
14. Harris G. US creates ethics panel on priority for flu shots. New York Times Oct. 28:2004;18
15. Notice to readers: delayed influenza vaccine availability for 2001-02 season and supplemental recommendations of the advisory committee on immunisation practices. MMWR Morbid Mortal Wkly Rep 2001; 50: 582-85.
16. Interim estimates of populations targeted for influenza vaccination from 2002 national health interview survey data and estimates for 2004 based on influenza shortage priority groups. Atlanta: Centers for Disease Control and Prevention, Oct 11, 2004: http://www.cdc.gov/flu/professionals/vaccination/pdf/ targetpopchart.pdf (accessed Nov 28, 2004).
17. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science. 301:2003;804
18. Stephenson I, Roper JP, Nicholson KG. Healthcare workers and their attitudes to influenza vaccination. Commun Dis Public Health. 5:2002;247-252
19. Fedson DS. Pandemic influenza and the global vaccine supply. Clin Infect Dis. 36:2003;1552-1561
20. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health. 3:2000;32-38